Navigation Links
Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
Date:2/19/2009

s during 2009; - FIRAZYR (icatibant) for the symptomatic treatment of acute attacks of HAE in certain European and Latin American countries during 2009; - INTUNIV (guanfacine extended release) for use in the treatment of ADHD in children and adolescents in the US in the second half of 2009; - FOSRENOL (lanthanum carbonate) in the pre-dialysis Chronic Kidney Disease market in the US in 2009 subject to ongoing discussions with the FDA to determine whether FOSRENOL can launch in this indication without conducting additional clinical outcomes trials; - DAYTRANA (methylphenidate transdermal system) for use in the treatment of ADHD in children in the EU in 2009 and adolescents in the US in 2010; - VYVANSE (lisdexamfetamine dimesylate) for use in the treatment of ADHD in children in Canada during 2010; and - Velaglucerase alfa for the treatment of Gaucher disease in the US and the EU in 2010.

CASHFLOW AND LIQUIDITY

Shire's robust balance sheet includes $218 million of cash and cash equivalents at December 31, 2008. We generated $800 million of cash from operating activities during the year. Shire has no debt or facilities maturing in the next three years and substantially all of Shire's debt relates to its $1.1 billion 2.75% convertible bonds which mature in 2014, although these include a put option which could require repayment in 2012. In addition, Shire has a committed facility until 2012 of $1.2 billion, which is currently undrawn.

DIVIDEND

In respect of the six months to December 31, 2008 the Board has resolved to pay a second interim dividend of 7.761 US cents per ordinary share (2007: 6.469 US cents per ordinary share). Together with the first interim payment of 2.147 US cents per ordinary share (2007: 2.147 US cents per ordinary share), this represents total dividends for 2008 of 9.9
'/>"/>

SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
2. Shire plc: Change to Directors Details
3. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
4. Shires New Product Portfolio Delivers Strong Quarterly Performance
5. Change of Name to Shire plc
6. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
7. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
8. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
9. Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
10. Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
11. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... N.J., Dec. 14 The third edition ... , published by the Infusion ... treatment for anthracycline extravasation.(1) Anthracyclines are a ... and epirubicin that have been used in the ... early 1970s.(2) ,, According to the ...
(Date:12/14/2009)... -- Nektar Therapeutics (Nasdaq: NKTR ) announced ... serve on its board of directors. Winger ... 35 years of experience in corporate management, financial ... extensive industry perspective at an important time in ... and CEO of Nektar and member of the ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3
... Gov. Jim Doyles effort to keep Wisconsins five military ... and not just because those bases bring nearly $850 ... a hidden fortress of ideas and materials to be used ... to the attention of national security policymakers. , ,Doyle toured ...
... EAU CLAIRE, Wis. S&C Bank-Eau Claire has ... the entryway of Schneider Social Science Hall at the ... Business. , ,The S&C Bank gift to the UW-Eau ... the Promise of Excellence, the foundation's ongoing campaign for the ...
... across America, kids are starting back to school this ... are packing cell phones in their backpacks. , ,That ... example local to Silicon Valley, administrators at San Mateo ... the use of camera and video phones. Echoing the ...
Other Biology Technology:Wisconsins untapped defense might: why saving military bases is just a start 2Wisconsins untapped defense might: why saving military bases is just a start 3UW-Eau Claire receives $35,000 remodeling gift 2Will mobile phones go back to school? 2Will mobile phones go back to school? 3Will mobile phones go back to school? 4
(Date:12/14/2009)... from the Astrobiology Centre (INTA-CSIC) has shown that hydrogen ... formation of the most basic biological molecules can be ... carry out this study, published in the journal ... conditions of the early Earth. , "We have shown ... it produces hydrogen cyanide, a substance that could have ...
(Date:12/13/2009)... help to engineer plants that take advantage of elevated ... could help to engineer crops that take advantage of ... dioxide they need for photosynthesis through microscopic breathing pores ... of the gas gained, they lose hundreds of water ... to save water when CO 2 is abundant, ...
(Date:12/11/2009)... BATON ROUGE, LAKeeping with the global "green" ... environmental education lessons to enhance students, science ... education into the curriculum raises not just ... test scores in other subject areas. Naturally, ... to integrate these relevant lessons into the ...
Breaking Biology News(10 mins):Prussian blue linked to the origin of life 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Students learn environmental stewardship, improve science scores 2Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 1Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 2Stemedica 26apos 3Bs President Delivers Keynote Address At Swiss Russian Forum 57458 3Chicago Lawyers Secure Record 2425 Million Cook County Jury Verdict for Schaumburg Accident Victim 57456 1Chicago Lawyers Secure Record 2425 Million Cook County Jury Verdict for Schaumburg Accident Victim 57456 2Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 1Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 2Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 3Dean MacCarter Ph D Addressed Differentiation of Responder vs Non Responder CRT Status with Low Level Exercise at HFSA13th Annual Scientific Meeting 57454 4
... how the plagues of the Middle Ages have made around ... some time that these individuals carry a genetic mutation (known ... of the immune system but have been unable to account ... relatively low levels in areas bordering the Mediterranean. , They ...
... differentially expressed genes that are potentially responsible for ... identify biological similarities between genes, publications from MEDLINE ... and combinations of gene name with specific keywords ... known genes and 3,731 keywords were generated and ...
... more partners than their counterparts did in the years before ... to a new report in the American Journal of Health ... and 2000 reported having more sexual partners, more unprotected sex ... and 1996, say Marguerita Lightfoot, Ph.D. and colleagues at the ...
Other Biology News:Biologists discover why 10% of Europeans are safe from HIV 2Youth With HIV Take More Risks After New Meds Introduced 2
... of integrins in vascular proliferation, adhesion, and ... family of cell adhesion receptors consists of ... an a and b subunit that associate ... functional diversity of the integrin family are ...
... GeneTraffic is built to be a straightforward, ... provides visual and computational tools to allow ... analysis. , Data and Project Management ... MIAME (Minimum Information About a Microarray Experiment) ...
... siTrio siRNA --- a cocktail of ... gene of interestis our most popular product. ... than 75% knockdown of your target gene ... siRNA for transfection and confirmation of optimal ...
... of 3 siRNAs specifically targeted to your ... product. The siTrio reagent guarantees you get ... gene when used under standard conditions (100 ... optimal transfection with one of B-Bridges controls). ...
Biology Products: